Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Group C sensory nerve fibers, commonly known as **C fibers**, are the smallest-diameter, unmyelinated, slow-conducting afferent fibers within the peripheral and central nervous systems[1][2][3]. They respond to thermal, mechanical, chemical, and pruritic (itch-inducing) stimuli and are polymodal in function. C fibers are especially known for transmitting the dull, burning pain perceived after the initial sharp pain (conveyed by A-delta fibers), as well as warmth, itch, and pleasant touch in subtypes[1][2]. They terminate as free nerve endings in peripheral tissues and connect centrally to the superficial laminae of the dorsal horn in the spinal cord where they contribute to the first stage processing of noxious and thermal stimuli[1][2]. Their activation is relevant to chronic pain, central sensitization, and various neuropathic conditions; they are distinguished from other pain-sensing fibers by their structure (Remak bundles with Schwann cells) and neuropeptide content or isolectin binding (peptidergic/non-peptidergic)[2]. While not a receptor or enzyme, their molecular targets (such as TRPV1, TRPA1, and Mrgprs) serve as drug targets for pain and itch therapies[1][2].
TRPV1 agonism (activates pain transmission); Blockade of voltage-gated calcium channels (reduces neurotransmitter release, e.g., by gabapentinoids); Inhibition/antagonism of substance P and CGRP signaling (blocks synaptic pain transmission); Desensitization via repeated capsaicin application (reduces pain response).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Group C sensory nerve fiber (C fiber).